Drug-induced psoriasis: clinical perspectives
Deepak MW Balak, Enes Hajdarbegovic Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands Abstract: Exposure to certain drugs can elicit an induction or exacerbation of psoriasis. Although well-conducted systematic studies on drug-related psoriasis are mos...
Saved in:
Main Authors: | Balak DMW, Hajdarbegovic E |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/b3309adb24cc441e9dd0bb9f6c2f7ff9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic utility of Ki-67 and Cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis
by: Engin Sezer, et al.
Published: (2015) -
Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India
by: Budamakuntla L, et al.
Published: (2019) -
Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial
by: Luis Puig, et al.
Published: (2021) -
Drug Intake and Actinic Keratosis: A Case-Control Study
by: Andrea Sechi, et al.
Published: (2021) -
Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
by: Gabriela Rossi, et al.
Published: (2021)